Current Drug Safety

Editor-in-Chief:

Dr. Seetal Dodd
University of Melbourne
Geelong, Melbourne
Australia

Back

Evolving Paradigms in Pharmacovigilance

Volume:1   Issue:2
Pp: 127-134
Wendy Brewster, Trevor Gibbs, Karol LaCroix, Alison Murray, Michael Tydeman and June Almenoff
DOI: 10.2174/157488606776930599

Psychiatric Side Effects of Interferon Treatment

Volume:1   Issue:2
Pp: 143-150
Scott B. Patten
DOI: 10.2174/157488606776930562

Exogenous Surfactant in Paediatric Acute Lung Injury and Acute Respiratory Distress Syndrome

Volume:1   Issue:2
Pp: 159-168
Stephen D. Playfor and Venkata K.T. Nootigattu
DOI: 10.2174/157488606776930553

Sirolimus Early Graft Nephrotoxicity: Clinical and Experimental Data

Volume:1   Issue:2
Pp: 179-187
Nicolas Pallet, Eric Thervet, Christophe Legendre and Dany Anglicheau
DOI: 10.2174/157488606776930580

The Safety of the Temozolomide in Patients with Malignant Glioma

Volume:1   Issue:2
Pp: 205-222
Alessandro Dario and Giustino Tomei
DOI: 10.2174/157488606776930535